CSS
VTYX

Cubist Systematic Strategies’s Ventyx Biosciences VTYX Stock Holding History

Cubist Systematic Strategies’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-149,500
Closed -$345K – 3547
2024
Q2 		$345K Buy
149,500
+93,247
+166% +$387K ﹤0.01% 2293
2024
Q1 		$309K Sell
56,253
-274,464
-83% -$1.26M ﹤0.01% 2858
2023
Q4 		$817K Buy
+330,717
New +$3.14M 0.01% 2200
2023
Q3 		– Sell
-4,179
Closed -$137K – 3970
2023
Q2 		$137K Buy
+4,179
New +$144K ﹤0.01% 2922
2022
Q4 		– Sell
-24,089
Closed -$841K – 4628
2022
Q3 		$841K Buy
+24,089
New +$533K ﹤0.01% 2765
2022
Q2 		– Sell
-26
Closed – – 4594
2022
Q1 		$0 Buy
+26
New +$347 ﹤0.01% 3791

Other funds holding VTYX

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cubist Systematic Strategies's VTYX Position: Q3 2024 in Review

Cubist Systematic Strategies sold out of Ventyx Biosciences (VTYX) in Q3 2024, closing a stake of 149,500 shares — an estimated $345K sold.

Cubist Systematic Strategies first reported a position in VTYX in Q1 2022 and held it in 6 quarters. The position peaked at $841K in Q3 2022. 118 funds tracked by Wall St. Rank hold VTYX as of Q3 2024.

  • Cubist Systematic Strategies reported no remaining Ventyx Biosciences position as of Q3 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 149,500 Ventyx Biosciences shares in Q3 2024, an estimated $345K.
  • Cubist Systematic Strategies first reported a position in Ventyx Biosciences in Q1 2022 and held it in 6 quarters.
  • Cubist Systematic Strategies's Ventyx Biosciences position peaked at $841K in Q3 2022.
  • 118 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q3 2024.

Based on Cubist Systematic Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.